Enviomycin is a naturally derived cyclic peptide antibiotic and antitubercular agent, also known as Tuberactinomycin N. It is structurally related to viomycin and belongs to the tuberactinomycin group of antibiotics. Enviomycin was isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus.
Enviomycin is classified by the WHO ATC system as an antitubercular antibiotic, with ATC code J04AB06. It has been used in the treatment of tuberculosis and has a marketing authorization in Japan.
Enviomycin is a cyclic basic peptide antibiotic with activity against Mycobacterium tuberculosis. It is closely related to viomycin and other tuberactinomycin antibiotics.
The compound has the molecular formula C₂₅H₄₃N₁₃O₁₀ and molecular weight 685.70 g/mol. Its CAS Registry Number is 33103-22-9.
Swapnroop Drugs and Pharmaceuticals provides Enviomycin for qualified pharmaceutical manufacturing, research, development and pharmaceutical sourcing requirements.
Enviomycin is a specialized antitubercular antibiotic pharmaceutical ingredient and should be handled according to applicable pharmaceutical quality and regulatory requirements.
Enviomycin belongs to the tuberactinomycin family of cyclic peptide antibiotics. Like related tuberactinomycin/viomycin compounds, it acts on bacterial protein synthesis and exhibits activity against mycobacteria.
Its antibacterial activity is associated particularly with inhibition of bacterial protein synthesis, contributing to its antimycobacterial effect.
Enviomycin is associated with:
| Parameter | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| pH (1% Solution) | 2.0 – 4.0 |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 1.0% |
| Water Content | NMT 1.0% |
| Melting Point | 150°C – 154°C |